Telavancin versus standard therapy for treatment of complicated skin and skin structure infections caused by gram-positive bacteria: FAST 2 study (Q34509652)
scientific article
Language:
(P31) (Q13442814)
(P50) (Q63144471)
(Q115862748)
(Q115862786)
(Q115862789)
(P304) 862-867
(P407) (Q1860)
(P433) 3
(P478) 50
(P577) Wednesday, March 1, 2006
(P921) (Q857288)
(P1104) 6
(P1433) (Q578004)
(P1476) "Telavancin versus standard therapy for treatment of complicated skin and skin structure infections caused by gram-positive bacteria: FAST 2 study" (language: en)
(P2093) Vivian H Chu
William D O'Riordan
Brian L Warren
Lala M Dunbar
David M Young
Marc Vallée
Joel Morganroth
Michael M Kitt
FAST 2 Investigator Group
(P2860) (Q24556635)
(Q28235095)
(Q34390668)
(Q33554391)
(Q30977541)
(Q35882353)
(Q40512558)
(Q40130630)
(Q42606627)
(Q28131787)
(Q42743595)
(Q41714469)
(Q43553034)
(Q44938149)
(Q44855208)
(Q44803993)
(Q44413098)
(Q44135225)
(Q43723787)
other details
description scientific article

External Links